---
schema_version: "secwatch.filing_event.v1"
accession: "0001585364-25-000153"
form_type: "8-K"
ticker: "PRGO"
cik: "0001585364"
company_name: "PERRIGO Co plc"
filed_at: "2025-11-05T23:59:59+00:00"
generated_at: "2026-05-17T00:17:26.051758+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Perrigo Q3 adj EPS $0.80 flat YoY; cuts FY25 guide; starts infant formula review

## Summary
- Q3 net sales $1.04B (-4.1% YoY); adj EPS $0.80 vs $0.81; reported EPS $0.09 vs -$0.13.
- FY25 outlook lowered: net sales growth -2.5% to -3.0%, adj EPS $2.70-$2.80 (5%-9% YoY growth).
- Initiates strategic review of infant formula business; continues oral care review; Dermacosmetics sale on track for Q1 2026.
- OTC store brand gained dollar, unit, and volume share in 5 of 7 categories despite soft market.
- YTD adj operating income up 9.8% to $455M; benefits from Project Energize and Supply Chain Reinvention.

## SEC filing metadata
- accession: 0001585364-25-000153
- form_type: 8-K
- ticker: PRGO
- cik: 0001585364
- company_name: PERRIGO Co plc
- filed_at: 2025-11-05T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1585364/000158536425000153/0001585364-25-000153-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1585364/000158536425000153/prgo-20251105.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001585364-25-000153
- JSON: https://secwatch.observer/filing/0001585364-25-000153.json
- Plain text: https://secwatch.observer/filing/0001585364-25-000153.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.